Global Data’s Medical Devices sector report, “Cochlear Implants -
Medical Devices Pipeline Assessment, 2016" provides an overview of
Cochlear Implants currently in pipeline stage. A cochlear implant is an implanted
electronic hearing device, designed to produce useful hearing sensations to a
person with severe to profound nerve deafness by electrically stimulating
nerves inside the inner ear.
These implants usually consist of 2 main components: The
externally worn microphone, sound processor and transmitter system. The implanted
receiver and electrode system, which contains the electronic circuits that
receive signals from the external system and send electrical currents to the
inner ear.
Currently made devices have a magnet that holds the external
system in place next to the implanted internal system. The report provides
comprehensive information on the pipeline products with comparative analysis of
the products at various stages of development. The report reviews major players
involved in the pipeline product development. It also provides information about
clinical trials in progress, which includes trial phase, trial status, trial
start and end dates, and, the number of trials for the key Cochlear Implants
pipeline products.
This report is prepared using data sourced from in-house
databases, secondary and primary research by Global Data’s team of industry
experts.
Complete report details @ https://www.wiseguyreports.com/reports/417084/cochlear-implants-medical-devices-pipeline-assessment-2016
*Note: Certain sections in the report may be removed or altered
based on the availability and relevance of data in relation to the equipment
type.
Scope
- Extensive coverage of the Cochlear Implants under development
- The report reviews details of major pipeline products which
includes, product description, licensing and collaboration details and other
developmental activities
- The report reviews the major players involved in the development
of Cochlear Implants and list all their pipeline projects
- The coverage of pipeline products based on various stages of
development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials
specific to pipeline products
- Recent developments in the segment / industry
Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and
insights to improve R&D strategies
- Identify emerging players with potentially strong product
portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Cochlear
Implants under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major
players with the most promising pipeline
- In-depth analysis of the product’s current stage of development,
territory and estimated launch date
Request a sample report @ https://www.wiseguyreports.com/sample_request/417084/cochlear-implants-medical-devices-pipeline-assessment-2016
Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introductions 6
2.1 Cochlear Implants Overview 6
3 Products under Development 7
3.1 Cochlear Implants - Pipeline Products by Stage of
Development 7
3.2 Cochlear Implants - Pipeline Products by Segment 8
3.3 Cochlear Implants - Pipeline Products by Territory 9
3.4 Cochlear Implants - Pipeline Products by Regulatory Path
10
3.5 Cochlear Implants - Pipeline Products by Estimated
Approval Date 11
4 Cochlear Implants - Pipeline Products under Development
by Companies 12
4.1 Cochlear Implants Companies - Pipeline Products by
Stage of Development 12
4.2 Cochlear Implants - Pipeline Products by Stage of
Development 13
Make an enquiry
before buying this Report @ https://www.wiseguyreports.com/enquiry/417084/cochlear-implants-medical-devices-pipeline-assessment-2016
5 Cochlear Implants Companies and Product Overview 14
5.1 Advanced Bionics, LLC Company Overview 14
5.1.1 Advanced Bionics, LLC Pipeline Products &
Ongoing Clinical Trials Overview 14
5.2 Ceragenix Pharmaceuticals, Inc. (Inactive) Company
Overview 16
5.2.1 Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline
Products & Ongoing Clinical Trials Overview 16
5.3 Hannover Medical School Company Overview 17
5.3.1 Hannover Medical School Pipeline Products &
Ongoing Clinical Trials Overview 17
5.4 Labyrinth Devices Company Overview 18
5.4.1 Labyrinth Devices Pipeline Products & Ongoing
Clinical Trials Overview 18
5.5 Northwestern University Company Overview 19
5.5.1 Northwestern University Pipeline Products &
Ongoing Clinical Trials Overview 19
5.6 Oticon Medical AB Company Overview 20
5.6.1 Oticon Medical AB Pipeline Products & Ongoing
Clinical Trials Overview 20
5.7 OtoKinetics Company Overview 21
5.7.1 OtoKinetics Pipeline Products & Ongoing
Clinical Trials Overview 21
5.8 Sonova Holding AG Company Overview 23
5.8.1 Sonova Holding AG Pipeline Products & Ongoing
Clinical Trials Overview 23
5.9 Tel Aviv Sourasky Medical Center Company Overview 25
5.9.1 Tel Aviv Sourasky Medical Center Pipeline Products
& Ongoing Clinical Trials Overview 25
5.10 The University of Utah Company Overview 26
5.10.1 The University of Utah Pipeline Products &
Ongoing Clinical Trials Overview 26
5.11 Trinity College Dublin Company Overview 28
5.11.1 Trinity College Dublin Pipeline Products &
Ongoing Clinical Trials Overview 28
5.12 University of Michigan Pediatric Device Consortium
Company Overview 29
Check Discount on
this report @ https://www.wiseguyreports.com/check_discount/417084/cochlear-implants-medical-devices-pipeline-assessment-2016
5.12.1 University of Michigan Pediatric Device Consortium
Pipeline Products & Ongoing Clinical Trials Overview 29
6 Cochlear Implants- Recent Developments 30
6.1 Nov 16, 2015: Advanced Bionics Launches the Naída CI
Q90 Sound Processor in North America 30
6.2 Nov 16, 2015: First half results 2015/16: Solid
performance in hearing instruments - held back by CI and FX 31
6.3 Oct 27, 2015: Parkinson’s study patients reach 42
weeks post NTCELL implant 33
6.4 Oct 01, 2015: Cochlear Lifetime Commitment Continues
for Recipients of First Commercially Available Cochlear Implant 33
6.5 Aug 18, 2015: AB announces FDA approval of Naida CI
Q90 EAS, new sound processor 34
6.6 Aug 18, 2015: LCT planning to resume control of
NTCELL manufacture 35
6.7 Aug 13, 2015: Overlake Medical Center is First in
State to Use World’s Thinnest Cochlear Implant 35
6.8 Jul 01, 2015: Cochlear Combines the World's Thinnest
Cochlear Implant Platform with the Industry's Thinnest Full Length Electrode 36
6.9 Jun 24, 2015: FDA Approves Technology Upgrade for
Recipients of First Commercially Available Cochlear Implant 36
6.10 Jun 14, 2015: NTCELL Clinical Study in Parkinson’s
Meets Endpoints 37
6.11 May 28, 2015: Advanced Bionics Announces TÜV
Approval of Naída CI Q90 EAS 38
6.12 May 26, 2015: Chris Smith Announced As Incoming
Chief Executive Officer Of Cochlear 39
6.13 May 19, 2015: Sonova continues to deliver solid
sales growth, margin expansion and strong cash flow performance 40
6.14 Apr 21, 2015: Cochlear: Judgment Entered In US
Patent Infringement Case 42
6.15 Mar 25, 2015: Patient at UNC Hospitals is first in
U.S. to receive newly approved cochlear implant 43
7 Appendix 44
7.1 Methodology 44
7.2 About GlobalData 46
7.3 Contact Us 47
7.4 Disclaimer 47
Contact
US:
NORAH
TRENT
Partner
Relations & Marketing Manager
sales@wiseguyreports.com
Ph:
+1-646-845-9349 (US)
Ph: +44
208 133 9349 (UK)
No comments:
Post a Comment